Speaking at the above panel discussion is Mr Young-ok Kim, Director, Clinical Trials Mgt, Risk Prevention Policy, Korea Food and Drug Administration (KFDA), Republic Of Korea. He will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012
Mr Kim is the director of the Clinical Trials Management Division, Risk Prevention Policy Bureau, KFDA. In this division he is in charge of policies related to clinical trials of drugs, medical devices, laboratory animals and experimental animal laboratories. He also handles the accreditation of institutions for clinical trials, IND approvals, etc. Mr Kim has previously worked in positions of increasing responsibility in KFDA for toxicology and drug safety.
Mr Kim will be discussing about the following issues:
Regulatory panel: Overcoming regulatory barriers in Asia to fast-track clinical trials
1. Identifying crucial compliance areas in Asian regulations for accelerated drug approval
2. Mapping the direction of regulatory affairs for Asia in the next five years and identifying areas of improvements
3. Developing a platform to enhance two-way communications between regulators and industry for improved regulatory compliance